A phase I study evaluating combined nimotuzumab and neoadjuvant chemoradiotherapy followed by surgery in locally advanced esophageal cancer
Crossref DOI link: https://doi.org/10.1007/s00280-019-03944-w
Published Online: 2019-09-09
Published Print: 2019-11
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Qi, Saichun
Mao, Ya
Jiang, Mingjun
Text and Data Mining valid from 2019-09-09
Version of Record valid from 2019-09-09
Article History
Received: 25 January 2019
Accepted: 28 August 2019
First Online: 9 September 2019
Compliance with ethical standards
:
: The author(s) declare that they have no competing interests.